BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9324018)

  • 1. H-ras oncogene point mutations in arthritic synovium.
    Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
    Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
    Banerjee SK; Makdisi WF; Weston AP; Campbell DR
    Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to verify H-ras mutations in arthritic synovium: comment on the article by Roivainen et al.
    Roivainen A; Zhu F; Sipola E; Yli-Jama T; Toivanen P
    Arthritis Rheum; 2001 Nov; 44(11):2705. PubMed ID: 11710728
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of the myc-family proto-oncogenes and related genes max and mad in synovial tissue.
    Roivainen A; Pirilä L; Yli-Jama T; Laaksonen H; Toivanen P
    Scand J Rheumatol; 1999; 28(5):314-8. PubMed ID: 10568429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
    Xu KM
    Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
    Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
    Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas.
    Sukumar S; Armstrong B; Bruyntjes JP; Leav I; Bosland MC
    Mol Carcinog; 1991; 4(5):362-8. PubMed ID: 1680340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
    Dieterle CP; Conzelmann M; Linnemann U; Berger MR
    Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
    Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
    Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice.
    Furuya N; Kawa S; Akamatsu T; Furihata K
    Gastroenterology; 1997 Aug; 113(2):593-8. PubMed ID: 9247481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
    Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
    Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients.
    Salbe C; Trevisiol C; Ferruzzi E; Mancuso T; Nascimbeni R; Di Fabio F; Salerni B; Dittadi R
    Int J Biol Markers; 2000; 15(4):300-7. PubMed ID: 11192825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.